CN115006296A - A kind of breath-removing composition and application in oral care products - Google Patents
A kind of breath-removing composition and application in oral care products Download PDFInfo
- Publication number
- CN115006296A CN115006296A CN202210878310.8A CN202210878310A CN115006296A CN 115006296 A CN115006296 A CN 115006296A CN 202210878310 A CN202210878310 A CN 202210878310A CN 115006296 A CN115006296 A CN 115006296A
- Authority
- CN
- China
- Prior art keywords
- zinc
- breath
- removing composition
- oral care
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 65
- 239000011701 zinc Substances 0.000 claims abstract description 65
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 65
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 17
- 238000000855 fermentation Methods 0.000 claims abstract description 12
- 230000004151 fermentation Effects 0.000 claims abstract description 12
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 29
- 239000011746 zinc citrate Substances 0.000 claims description 29
- 235000006076 zinc citrate Nutrition 0.000 claims description 29
- 229940068475 zinc citrate Drugs 0.000 claims description 29
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000002324 mouth wash Substances 0.000 claims description 14
- 239000000606 toothpaste Substances 0.000 claims description 14
- 229940034610 toothpaste Drugs 0.000 claims description 14
- 229940051866 mouthwash Drugs 0.000 claims description 13
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 7
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229920001992 poloxamer 407 Polymers 0.000 claims description 5
- 229940044476 poloxamer 407 Drugs 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims 3
- 229960000502 poloxamer Drugs 0.000 claims 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims 1
- 229940085605 saccharin sodium Drugs 0.000 claims 1
- 239000004246 zinc acetate Substances 0.000 claims 1
- 229960000314 zinc acetate Drugs 0.000 claims 1
- 235000013904 zinc acetate Nutrition 0.000 claims 1
- 235000019606 astringent taste Nutrition 0.000 abstract description 15
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 abstract description 10
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 abstract description 10
- 210000002200 mouth mucosa Anatomy 0.000 abstract description 2
- 206010006326 Breath odour Diseases 0.000 description 40
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 28
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 26
- 208000032139 Halitosis Diseases 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
- 210000000214 mouth Anatomy 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000003296 saliva Anatomy 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 229960000892 attapulgite Drugs 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 229910052625 palygorskite Inorganic materials 0.000 description 3
- 208000028169 periodontal disease Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 150000003751 zinc Chemical class 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- 208000005888 Periodontal Pocket Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- DBGSRZSKGVSXRK-UHFFFAOYSA-N 1-[2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]acetyl]-3,6-dihydro-2H-pyridine-4-carboxylic acid Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CCC(=CC1)C(=O)O DBGSRZSKGVSXRK-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- XYWDPYKBIRQXQS-UHFFFAOYSA-N di-isopropyl sulphide Natural products CC(C)SC(C)C XYWDPYKBIRQXQS-UHFFFAOYSA-N 0.000 description 1
- LJSQFQKUNVCTIA-UHFFFAOYSA-N diethyl sulfide Chemical compound CCSCC LJSQFQKUNVCTIA-UHFFFAOYSA-N 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种去口气组合物及在口腔护理产品中的应用,属于口腔护理技术领域。该去口气组合物包括生物锌‑酵母/锌发酵产物,所述生物锌在口腔护理产品中的含量为0.1%‑10%。将酵母/锌发酵产物首次应用在去口气功能口腔护理产品中,在吸附口气中硫化物的同时,解决常规有机锌溶解度低及无机锌离子收敛性强的问题。所得产品能够长时间抑制口气中硫化物、清新口气且无明显涩感或口腔黏膜收敛感。The invention discloses a breath-removing composition and its application in oral care products, belonging to the technical field of oral care. The breath-removing composition comprises biological zinc-yeast/zinc fermentation products, and the content of the biological zinc in the oral care product is 0.1%-10%. The yeast/zinc fermented product was used for the first time in oral care products with breath-removing function. While adsorbing sulfide in breath, it solved the problems of low solubility of conventional organic zinc and strong astringency of inorganic zinc ions. The obtained product can inhibit sulfide in the breath for a long time, refresh the breath without obvious astringency or astringency of the oral mucosa.
Description
技术领域technical field
本发明涉及口腔护理技术领域,具体涉及一种去口气组合物及在口腔护理产品中的应用。The invention relates to the technical field of oral care, in particular to a breath removing composition and its application in oral care products.
背景技术Background technique
口气又称口臭,指呼吸或张口时散发出异味的一种症状。口臭在成年人中相当普遍,流行病学调查显示口臭的发病率较高。口臭分为真性口臭(Genuine Halitosis)、假性口臭(Pseudo Halitosis)和恐臭症(Halitophobia)。真性口臭是指他人能够感觉到的来自口腔的明显异味。真性口臭分为生理性口臭(Physiologic Halitosis)和病理性口臭(Pathologic Halitosis)。生理性口臭产生于口腔腐化过程,没有会引起口臭的特殊疾病或病理状况存在。口臭主要来源是舌背的后方。食物因素(大蒜洋葱等)引起的暂时性口臭也归于此类。病理性口臭分为口源性口臭和非口源性口臭。口源性口臭由于口腔卫生状况差或某些口腔疾病而引起的,例如牙周病、未治愈的龋齿、口干症等引起的口臭。非口源性口臭由鼻腔、咽喉、肺部或上消化系统疾病全身疾病如尿毒症、肝硬化等造成的口臭。假性口臭指患者本人自我感觉有口腔异味,检查结果为阴性。此症状可通过解释说明和心理咨询得到改善者。恐臭症指经过真性或假性口臭的治疗后,患者仍坚持自己有口臭,经检查没有任何能引起口臭的因素存在。Bad breath, also known as bad breath, refers to a symptom of an unpleasant odor when breathing or opening the mouth. Bad breath is fairly common among adults, and epidemiological surveys have shown a higher incidence of bad breath. Halitosis is divided into Genuine Halitosis, Pseudo Halitosis and Halitophobia. True halitosis is a distinct odor from the mouth that others can perceive. True halitosis is divided into physiological halitosis (Physiologic Halitosis) and pathological halitosis (Pathologic Halitosis). Physiological halitosis arises from the decay process of the oral cavity, and no specific diseases or pathological conditions exist that can cause halitosis. The main source of bad breath is the back of the tongue. Temporary bad breath caused by food factors (garlic, onions, etc.) also falls into this category. Pathological halitosis is divided into oral halitosis and non-oral halitosis. Oral halitosis is caused by poor oral hygiene or certain oral diseases, such as periodontal disease, uncured caries, xerostomia, etc. Non-oral halitosis is halitosis caused by diseases of the nasal cavity, throat, lungs or upper digestive system and systemic diseases such as uremia and liver cirrhosis. False halitosis refers to the patient's self-perceived oral odor, and the test result is negative. This symptom can be improved through explanation and psychological counseling. Odorphobia refers to the fact that after the treatment of real or false halitosis, the patient still insists that he has bad breath, and there is no factor that can cause bad breath after examination.
引发口臭的病因有口腔内因素、口腔外因素和精神性因素。三种因素中,口腔内因素是主要致病因素。曾有研究表明87%的口臭病人的致病因素来自于口腔(Delanghe G,Ghyselen J,Bollen C,et al.An inventory of patients’response to treatment at amulti-disciplinary breath odor clinic[J].Quintessence Int,1999,30:307-310.)。此外,某些精神疾病和系统性疾病也会引发口臭。The causes of bad breath include intraoral factors, extraoral factors and psychological factors. Among the three factors, oral factors were the main pathogenic factors. Studies have shown that 87% of the causative factors of halitosis patients come from the oral cavity (Delanghe G, Ghyselen J, Bollen C, et al. An inventory of patients'response to treatment at amulti-disciplinary breath odor clinic[J].Quintessence Int , 1999, 30:307-310.). In addition, certain psychiatric and systemic diseases can also cause bad breath.
据统计,80%-90%的口臭源于口腔,如龋病、牙周病、舌苔、食物嵌塞、不良修复体、口腔粘膜病等,其中龋齿和牙周病为最常见相关疾病。口腔内含有大量的微生物,其利用残留在口腔中的氨基酸、蛋白质等食物残渣分解代谢,产生令人不愉快的气味——挥发性硫化复合物(Volatile sulfur compounds,VSCs)。硫化物主要成分为硫化氢、甲基硫醇和乙基硫化物(Scully C,el-Maaytah M,Porter SR,et al. Breath odor:etippatheogenesis,assessment and management[J].Eur J Oral Sci,1997,105:287-293)。临床实验证明VSCs水平与口臭程度成正相关(NakanoY,Yoshimura M,KogaT.Correlation between oral malodor and periodontal bacteria[J].MicrobesInfect,2002,4(6):67)。According to statistics, 80%-90% of bad breath originates from the oral cavity, such as caries, periodontal disease, tongue coating, food impaction, poor restorations, oral mucosal diseases, etc. Among them, dental caries and periodontal disease are the most common related diseases. The oral cavity contains a large number of microorganisms, which catabolize and metabolize food residues such as amino acids and proteins remaining in the oral cavity to produce unpleasant odors—Volatile sulfur compounds (VSCs). The main components of sulfide are hydrogen sulfide, methyl mercaptan and ethyl sulfide (Scully C, el-Maaytah M, Porter SR, et al. Breath odor: etippatheogenesis, assessment and management [J]. Eur J Oral Sci, 1997, 105:287-293). Clinical experiments have shown that the level of VSCs is positively correlated with the degree of bad breath (NakanoY, Yoshimura M, KogaT.Correlation between oral malodor and periodontal bacteria[J].MicrobesInfect,2002,4(6):67).
目前,大多数研究认为口腔内引发口臭的微生物(主要是革兰阴性厌氧菌)主要集中在牙龈沟(牙周袋)和舌苔(Tonzetich J,McBride B C.Characterization of volatilesulphur production by pathogenic and non-pathogenic strains of oralBacteroides[J].Arch Oral Biol,1981,26: 963–969)。这与研究报道(刘兵红.口臭分类及相关病因分析[J].继续医学教育,2007,34:72-74)VSCs的口腔来源主要是牙龈沟(牙周袋)及舌背是相一致的。At present, most studies believe that the microorganisms (mainly Gram-negative anaerobic bacteria) that cause bad breath in the oral cavity are mainly concentrated in the gingival sulcus (periodontal pocket) and tongue coating (Tonzetich J, McBride B C. Characterization of volatilesulphur production by pathogenic and non -pathogenic strains of oral Bacteroides [J]. Arch Oral Biol, 1981, 26: 963–969). This is consistent with research reports (Liu Binghong. Classification of halitosis and analysis of related etiologies [J]. Continuing Medical Education, 2007, 34: 72-74) the oral sources of VSCs are mainly the gingival sulcus (periodontal pocket) and the back of the tongue. of.
专利《口腔用组合物中的柠檬酸锌小球》(ZL 03809346)采用柠檬酸锌作为抗牙垢物质加入到口腔用组合物中,锌盐的添加量为 0.001%-20%。专利《一种高效去渍增白牙膏及其制造方法》(ZL 200510026049.5)提及了一种美白牙膏的配比,柠檬酸锌为0.5%-3.5%,此专利认为柠檬酸锌能溶解结石和抑制菌斑钙化沉积,从而制止菌斑牙结石的形成。专利《包含碳酸钙和柠檬酸锌的牙膏》(ZL 200580026141.X)提及到一种牙膏组合物包含锌盐,锌盐以溶于水的柠檬酸锌形式存在,柠檬酸锌作为一种抗结石剂。专利《凹凸棒双氟牙膏的生产方法》(ZL 200810018916.4)所述凹凸棒双氟牙膏成分涉及柠檬酸锌,添加量为0.05%-1.0%,柠檬酸锌的作用为阻止牙石形成,抑制烟斑、茶斑等色素在牙齿表面的附着。专利《凹凸棒除烟渍牙膏的生产方法》(ZL 200810018908.X)提及柠檬酸锌的添加量与作用与前一篇专利相同。专利《用于治疗口腔疾病的药物牙膏及其制备方法》(ZL201010135299.3)所述牙膏含有柠檬酸锌,添加量为0.5%-2%,但是并未提及其作用。专利《一种除口臭、预防口腔溃疡的牙膏》(ZL 20101047150.7)所述牙膏包含柠檬酸锌成分,添加量为1%-2%,此发明认为在牙膏中加入柚皮苷、柠檬酸锌、桉叶油素等成分能够清除口腔异味、杀灭口腔有害细菌,柠檬酸锌具有除口臭、防止牙龈炎、牙结石、牙出血的功效。专利《包含氟化亚锡加柠檬酸锌和低水平水的洁齿剂》(ZL 200980162304.5)所述洁齿剂包含一钟锌离子来源,包含有机酸的锌盐,包含柠檬酸锌。专利《口腔护理组合物》(ZL201180018204.2)所述牙膏包含一种柠檬酸根离子源为微水溶性柠檬酸盐,此柠檬酸盐为柠檬酸锌。该柠檬酸根离子源至少占配方总量的0.6%以上。选择柠檬酸锌的原因为提供额外的乳浊效果来进一步改善产品的美观性。此专利认为锌离子对此组合物抗菌斑和抗牙垢性也是有价值的。专利《口腔护理组合物》(ZL 201180018162.2)所述组合物包含一种或多种锌离子源,该锌离子源为柠檬酸锌,有助于增加产品的美观性和稳定性。专利《包含醌和其它抗微生物剂的口腔护理组合物》(ZL 201080070593.9)所述组合物的抗微生物剂包含含锌化合物,柠檬酸锌为其中一种。专利《掩味的口腔护理组合物》(ZL 201180067627.3)所述组合物含有一系列香料成分用于掩盖口腔异味,其中含有金属盐,金属盐为柠檬酸锌。柠檬酸锌作为吸附口腔中硫化物应用多有报道,但由于柠檬酸锌低溶解度,较难达到有效作用浓度,并且一定浓度的锌离子在口腔中会带来明显涩感和收敛感,限制了其在口腔护理产品中的实际应用。The patent "Zinc Citrate Pellets in Oral Composition" (ZL 03809346) uses zinc citrate as an anti-tartar substance to be added to the oral composition, and the addition amount of zinc salt is 0.001%-20%. The patent "An efficient stain removal and whitening toothpaste and its manufacturing method" (ZL 200510026049.5) mentions the proportion of a whitening toothpaste, zinc citrate is 0.5%-3.5%, this patent believes that zinc citrate can dissolve calculus and Inhibits plaque calcification deposition, thereby preventing the formation of plaque and calculus. The patent "Toothpaste Containing Calcium Carbonate and Zinc Citrate" (ZL 200580026141.X) mentions that a toothpaste composition contains zinc salt, which exists in the form of zinc citrate dissolved in water, and zinc citrate acts as an anti-oxidant. Stone agent. The patent "Production Method of Attapulgite Double Fluoride Toothpaste" (ZL 200810018916.4), the attapulgite double fluoride toothpaste contains zinc citrate, and the addition amount is 0.05%-1.0%. The function of zinc citrate is to prevent the formation of calculus and inhibit smoke spots , the adhesion of pigments such as tea spots on the tooth surface. The patent "Production method of attapulgite toothpaste for removing smoke stains" (ZL 200810018908.X) mentions that the addition amount and function of zinc citrate are the same as the previous patent. The toothpaste described in the patent "Drug toothpaste for treating oral diseases and its preparation method" (ZL201010135299.3) contains zinc citrate in an addition amount of 0.5%-2%, but its function is not mentioned. The toothpaste described in the patent "A toothpaste for removing bad breath and preventing oral ulcers" (ZL 20101047150.7) contains zinc citrate in an amount of 1%-2%. This invention considers adding naringin, zinc citrate, Eucalyptol and other ingredients can remove bad breath and kill harmful bacteria in the mouth. Zinc citrate has the effect of removing bad breath, preventing gingivitis, calculus, and bleeding teeth. The patent "Dentifrice Containing Stannous Fluoride Plus Zinc Citrate and Low Levels of Water" (ZL 200980162304.5) describes the dentifrice containing a source of zinc ions, including zinc salts of organic acids, including zinc citrate. The toothpaste described in the patent "Oral Care Composition" (ZL201180018204.2) contains a citrate ion source which is slightly water-soluble citrate, and the citrate is zinc citrate. The citrate ion source accounts for at least 0.6% of the total formula. Zinc citrate was chosen to provide an additional opacifying effect to further improve the aesthetics of the product. This patent believes that zinc ions are also valuable for the antiplaque and antitartar properties of the composition. The composition described in the patent "Oral Care Composition" (ZL 201180018162.2) contains one or more zinc ion sources, and the zinc ion source is zinc citrate, which helps to increase the aesthetics and stability of the product. In the patent "Oral Care Composition Containing Quinones and Other Antimicrobial Agents" (ZL 201080070593.9), the antimicrobial agent of the composition contains zinc-containing compounds, and zinc citrate is one of them. The patent "Taste-masked Oral Care Composition" (ZL 201180067627.3), the composition contains a series of fragrance ingredients for masking oral odor, which contains a metal salt, and the metal salt is zinc citrate. There are many reports on the application of zinc citrate as the adsorption of sulfide in the oral cavity. However, due to the low solubility of zinc citrate, it is difficult to achieve an effective concentration, and a certain concentration of zinc ions will bring obvious astringency and astringency in the oral cavity, which limits the Its practical application in oral care products.
目前,酵母/锌发酵产物主要作为化妆品实用,还没有将其用作去口气的研究。At present, yeast/zinc fermentation products are mainly used as cosmetics, and there is no research on their use as a deodorant.
发明内容SUMMARY OF THE INVENTION
针对现有技术中的缺陷,本发明提供了一种去口气组合物及在口腔护理产品中的应用,将酵母/锌发酵产物首次应用在去口气功能口腔护理产品中,在吸附口气中硫化物的同时,解决常规有机锌溶解度低及无机锌离子收敛性强的问题。In view of the defects in the prior art, the present invention provides a breath-removing composition and its application in oral care products. The yeast/zinc fermented product is applied to the oral care product with breath-removing function for the first time. At the same time, the problems of low solubility of conventional organic zinc and strong convergence of inorganic zinc ions are solved.
本发明提供的去口气组合物,包括生物锌,按重量百分比计,其在口腔护理产品中的含量为0.1%-10%;所述生物锌为酵母/发酵产物。The breath removing composition provided by the present invention includes biological zinc, and its content in oral care products is 0.1%-10% by weight; the biological zinc is a yeast/fermentation product.
所述组合物种酵母菌/锌发酵产物有酿酒酵母发酵制成,酵母发酵过程中,锌与氨基酸、多肽等高活性小分子物质以鳌合的形式存在,使无机锌转化为有机锌,降低了无机锌所特有的皮肤刺激性,更适用于口腔护理产品应用。The combined species of yeast/zinc fermentation product is prepared by fermentation of Saccharomyces cerevisiae. During the yeast fermentation process, zinc and amino acids, polypeptides and other highly active small molecular substances exist in the form of chelation, so that inorganic zinc is converted into organic zinc, reducing the amount of zinc. The skin irritation characteristic of inorganic zinc makes it more suitable for oral care product applications.
优选地,还包括有机锌或无机锌,包括有机锌或无机锌,所述生物锌与有机锌/无机锌的重量比为100:1-5:1;所述有机锌包括柠檬酸锌、乙酸锌、葡糖酸锌中的任意一种或多种,所述无机锌包括氯化锌或硫酸锌中的任意一种或多种。Preferably, it also includes organic zinc or inorganic zinc, including organic zinc or inorganic zinc, and the weight ratio of the biological zinc to the organic zinc/inorganic zinc is 100:1-5:1; the organic zinc includes zinc citrate, acetic acid Any one or more of zinc and zinc gluconate, and the inorganic zinc includes any one or more of zinc chloride or zinc sulfate.
优选地,所述生物锌与有机锌/无机锌的重量比为10:1。Preferably, the weight ratio of the biological zinc to the organic zinc/inorganic zinc is 10:1.
柠檬酸锌(有机锌)在组合物中一方面可作为抗菌物质,能够有效地抑制口腔中产挥发性硫化物细菌的生长,另一方面亦可提供与硫化物反应的锌离子。Zinc citrate (organic zinc) can be used as an antibacterial substance in the composition on the one hand, which can effectively inhibit the growth of volatile sulfide-producing bacteria in the oral cavity, and on the other hand, it can also provide zinc ions that react with sulfides.
一种上述的去口气组合物在口腔护理产品中的应用,所述口腔护理产品包括牙膏、牙粉、漱口水、口清新中的任意一种。An application of the above breath-removing composition in an oral care product, the oral care product includes any one of toothpaste, tooth powder, mouthwash, and mouth freshener.
优选地,所述去口气组合物中生物锌在口腔护理产品中的重量百分含量为0.1-10%;所述去口气组合物中有机锌或无机锌在口腔护理产品中的重量百分含量为0.01-2%。需要说明的是,有机锌或无机锌可选择的种类较多,且溶解度不同,其加入的含量应当以完全溶解为准。Preferably, the weight percent content of biological zinc in the oral care product in the breath-removing composition is 0.1-10%; the weight percent content of organic zinc or inorganic zinc in the oral care product in the breath-removing composition 0.01-2%. It should be noted that there are many types of organic zinc or inorganic zinc to choose from, and the solubility is different, and the added content should be based on complete dissolution.
一种漱口水,按重量百分比计,包括:上述的去口气组合物 0.1%-12%、山梨醇15%-25%、甘油5%-15%、丙二醇4%-6%、泊洛沙姆407 0.5%-1.5%、香精0.08%-0.12%、糖精钠0.01-0.03%、西吡氯铵0.04-0.06%,余量为水。A mouthwash, by weight percentage, comprising: 0.1%-12% of the above-mentioned breath removing composition, 15%-25% of sorbitol, 5%-15% of glycerin, 4%-6% of propylene glycol, poloxamer 407 0.5%-1.5%, essence 0.08%-0.12%, sodium saccharin 0.01-0.03%, cetylpyridinium chloride 0.04-0.06%, and the balance is water.
优选地,按重量份计,包括:权利要求1-2任一项所述的去口气组合物0.1%-10%、山梨醇15%-25%、甘油5%-15%、丙二醇4%-6%、泊洛沙姆407 0.5%-1.5%、香精0.08%-0.12%、糖精钠0.01-0.03%、西吡氯铵0.04-0.06%,余量为水。Preferably, in parts by weight, it comprises: 0.1%-10% of the breath-removing composition according to any one of claims 1-2, 15%-25% of sorbitol, 5%-15% of glycerol, 4% of propylene glycol- 6%, Poloxamer 407 0.5%-1.5%, essence 0.08%-0.12%, sodium saccharin 0.01-0.03%, cetylpyridinium chloride 0.04-0.06%, and the balance is water.
一种上述的漱口水的制备方法,包括以下步骤:A preparation method of the above-mentioned mouthwash, comprising the following steps:
(1)按重量百分比将泊洛沙姆407加入去离子水中,搅拌至完全溶解;加入糖精钠、西吡氯铵、上述的去口气组合物,搅拌至完全溶解;加入山梨醇、甘油,搅拌均匀,搅拌均匀制成水相;(1) Poloxamer 407 is added to deionized water by weight percentage, stirred to dissolve completely; Add sodium saccharin, cetyl pyridinium chloride, the above-mentioned breath-removing composition, stir to dissolve completely; Add sorbitol, glycerin, stir Evenly, stir to make the water phase;
(2)将香精加入丙二醇中搅拌均匀,制成油相;(2) adding essence into propylene glycol and stirring to make oil phase;
(3)搅拌条件下,将油相加入水相,搅拌20-30min,即得。(3) Under stirring conditions, add the oil phase to the water phase, and stir for 20-30min to obtain the result.
本发明技术方案具有如下优点:The technical scheme of the present invention has the following advantages:
首次将酵母/锌发酵产物在去口气功能口腔护理产品中应用,在吸附口气中硫化物同时,还解决常规有机锌溶解度低及无机锌离子收敛性强的问题。It is the first time that yeast/zinc fermentation products are used in oral care products with breath-removing function. At the same time of adsorbing sulfide in breath, it also solves the problems of low solubility of conventional organic zinc and strong astringency of inorganic zinc ions.
采用酵母/锌发酵产物与其他有机锌或无机锌复配,协同增强口气中硫化物吸收效率,同时提供良好产品口感。所得产品能够长时间抑制口气中硫化物、清新口气且无明显涩感或口腔黏膜收敛感。The yeast/zinc fermentation product is compounded with other organic zinc or inorganic zinc to synergistically enhance the absorption efficiency of sulfide in the breath, while providing a good product taste. The obtained product can inhibit sulfide in the breath for a long time, refresh the breath without obvious astringency or astringency of the oral mucosa.
具体实施方式Detailed ways
下面将对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions of the present invention will be described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
本发明中所涉及的酵母/锌发酵产物,INCI名:酵母菌/锌发酵产物,已列入《化妆品原料已使用目录》(2021版)中。The yeast/zinc fermentation product involved in the present invention, INCI name: yeast/zinc fermentation product, has been included in the "Catalogue of Cosmetic Raw Materials Used" (version 2021).
本发明所涉及的其他试剂如无特殊说明,均为普通市售产品。The other reagents involved in the present invention are common commercial products unless otherwise specified.
实施例1-5Examples 1-5
实施例按照表1的配方进行设计。The embodiment is designed according to the formula in Table 1.
表1Table 1
对比例1-6 对比例配方如表2所示。Comparative Examples 1-6 The formulations of the comparative examples are shown in Table 2.
表2Table 2
制备工艺:表1和表2中各实施例和对比例制备工艺采用以下方案,其中有未添加组分实施例则省去相应添加步骤。(1)将泊洛沙姆407加入去离子水中,搅拌至完全溶解;加入糖精钠、西吡氯铵、酵母/锌发酵产物、柠檬酸锌,搅拌至完全溶解;加入山梨醇、甘油,搅拌均匀,搅拌5min制成水相;(2)将香精加入丙二醇中搅拌均匀,制成油相;(3)搅拌条件下,将油相加入水相,搅拌20min。Preparation process: The preparation process of each embodiment and comparative example in Table 1 and Table 2 adopts the following scheme, and the corresponding addition step is omitted in the embodiment without added components. (1) Poloxamer 407 was added to deionized water, stirred until completely dissolved; added sodium saccharin, cetyl pyridinium chloride, yeast/zinc fermented product, zinc citrate, stirred until completely dissolved; added sorbitol, glycerin, stirred Evenly, stir for 5min to make water phase; (2) add essence into propylene glycol and stir to make oil phase; (3) under stirring condition, add oil phase to water phase and stir for 20min.
性能检测Performance testing
1、体外去口气功效测试—吸附口气中挥发性硫化物(硫化氢) 功效1. In vitro breath removal efficacy test - the effect of adsorbing volatile sulfide (hydrogen sulfide) in the breath
1.1测试方法1.1 Test method
取实施例和对比例中漱口水各9mL装入22毫升顶空进样瓶,空白对照组为9mL去离子水,注射器吸取1mL硫化氢水溶液标样,注入顶空进样瓶后迅速封盖,采用气相色谱仪配FPD+检测器结合顶空进样器设备检测硫化氢含量,记录硫化氢峰面积,根据硫化氢标准曲线计算每组样品中硫化氢含量,对照组为水溶液。Take 9 mL of the mouthwash in each of the examples and the comparative example and put them into a 22-mL headspace injection bottle. The blank control group is 9 mL of deionized water. The syringe draws 1 mL of the standard sample of hydrogen sulfide aqueous solution, and it is injected into the headspace injection bottle and quickly capped. The hydrogen sulfide content was detected by gas chromatograph with FPD+ detector combined with headspace sampler equipment, and the hydrogen sulfide peak area was recorded. The hydrogen sulfide content in each group of samples was calculated according to the hydrogen sulfide standard curve, and the control group was an aqueous solution.
1.2测试结果1.2 Test results
根据以下公式计算各组样品对硫化氢吸收率:吸收率(%)=[(空白对照硫化氢含量-实验组硫化氢含量)/空白对组照硫化氢含量] ×100Calculate the hydrogen sulfide absorption rate of each group of samples according to the following formula: absorption rate (%) = [(Hydrogen sulfide content in blank control group - hydrogen sulfide content in experimental group) / hydrogen sulfide content in blank control group] × 100
表3体外测试各实施例样品对硫化氢吸收率Table 3 in vitro test samples of each embodiment to hydrogen sulfide absorption rate
从表2结果可以看出,实施例中生物锌与有机锌或无机锌的组合具有协同增效效果,对硫化氢吸收率高。对比例2仅加入柠檬酸锌,其在有限溶解度下对硫化氢吸收作用有限;对比例3-4中加入了酵母 /锌发酵产物,其有显著的硫化氢吸收效果;单独加入无机锌的对比例5硫化氢吸收效果较好,但其在有效添加量下为带来明显涩感和收敛感,限制其在口腔护理产品中应用;对比例6中生物锌和有机锌的加入量较少,其比例为1:1,同样吸收效果不佳,其原因可能是有机锌形式锌离子活性未完全释放,从而影响二者组合的协同增效作用。It can be seen from the results in Table 2 that the combination of biological zinc and organic zinc or inorganic zinc in the examples has a synergistic effect and has a high absorption rate for hydrogen sulfide. Comparative example 2 only adds zinc citrate, which has a limited effect on hydrogen sulfide absorption under limited solubility; yeast/zinc fermentation products are added in comparative examples 3-4, which have a significant hydrogen sulfide absorption effect; The hydrogen sulfide absorption effect of the proportion 5 is better, but it brings obvious astringency and astringency under the effective addition amount, which limits its application in oral care products; the addition amount of biological zinc and organic zinc in the comparative example 6 is less, The ratio is 1:1, and the absorption effect is also poor. The reason may be that the zinc ion activity in the form of organic zinc is not fully released, thus affecting the synergistic effect of the combination of the two.
2、去除人体口气中硫化物功效测试2. Efficacy test of removing sulfide in human breath
2.1测试方法2.1 Test method
受试者为符合纳入及排除标准的患有口源性口臭的男性和女性,采集唾液后测试唾液中硫化氢含量,获得口气基线值。测试当天早上不进食不刷牙,采集唾液10mL气相色谱检测硫化氢含量,采用测试样品漱口30秒吐出,然后在10分钟内取唾液10mL,气相色谱仪测试漱口后唾液内硫化氢含量。每个受试者每天使用一款样品,连续测试5天至5款样品测试完毕。The subjects were men and women with oral halitosis who met the inclusion and exclusion criteria. After collecting saliva, the hydrogen sulfide content in the saliva was tested to obtain the baseline value of breath. In the morning of the test, people did not eat or brush their teeth, collect 10 mL of saliva to detect the hydrogen sulfide content by gas chromatography, gargle the test sample for 30 seconds and spit it out, and then take 10 mL of saliva within 10 minutes, and use gas chromatography to test the hydrogen sulfide content in the saliva after gargling. Each subject used one sample per day, and tested continuously for 5 days until 5 samples were tested.
2.2测试结果2.2 Test results
口气中硫化氢去除率按下式计算:去除率(%)=[(漱口前硫化氢含量-漱口后硫化氢含量)/漱口前硫化氢含量]×100The removal rate of hydrogen sulfide in the breath is calculated as follows: removal rate (%) = [(hydrogen sulfide content before rinsing - hydrogen sulfide content after rinsing) / hydrogen sulfide content before rinsing] × 100
表4漱口后口气中硫化氢去除率Table 4 Removal rate of hydrogen sulfide in breath after mouthwash
从表4结果可以看出,在使用对比例1样品漱口水无明显口气去除效果,硫化氢去除率小于10%。对比例2中的活性成分仅加入了酵母/锌提取物,硫化氢去除率同样不佳。实施例1和2中的酵母/锌提取物和柠檬酸锌的组合漱口水具有显著去除口气中硫化氢效果。说明二者具有协同增效作用。It can be seen from the results in Table 4 that there is no obvious breath removal effect when using the mouthwash of the sample of Comparative Example 1, and the hydrogen sulfide removal rate is less than 10%. The active ingredient in Comparative Example 2 only added yeast/zinc extract, and the hydrogen sulfide removal rate was also poor. The combined yeast/zinc extract and zinc citrate mouthwashes of Examples 1 and 2 had a significant effect of removing hydrogen sulfide from breath. It shows that the two have a synergistic effect.
3、口感测试3. Taste test
3.1测试方法3.1 Test method
招募20名志愿者进行实施例和对比例样品漱口测试,并填写问卷进行评分。评分标准设置为:5分—无不适感,不涩无收敛感;4 分—无明显不适感,无明显涩感或收敛感;3分--一般,有可感知涩感或收敛感;2分—明显不适感,明显涉感或收敛感;1分—非常不适,强烈涉感或收敛感。20 volunteers were recruited to perform the mouthwash test of the samples of the example and the comparative example, and filled out a questionnaire for scoring. The scoring standard is set as: 5 points - no discomfort, no astringency, no convergence; 4 points - no obvious discomfort, no obvious astringency or convergence; 3 points - fair, with perceptible astringency or convergence; 2 Score - obvious discomfort, obvious involvement or convergence; 1 - very discomfort, strong involvement or convergence.
3.2测试结果3.2 Test results
统计各实施例口感评分,结果取平均值,数据见表5。The mouthfeel scores of each embodiment were counted, and the results were averaged, and the data were shown in Table 5.
表5各实施例样品漱口口感测试评分Table 5 Mouthwash mouthfeel test score of each embodiment sample
从表5结果可以看出,添加酵母/锌发酵产物的漱口水样品无涩感或收敛感,入口使用性良好。As can be seen from the results in Table 5, the mouthwash samples to which the yeast/zinc fermented product was added had no astringency or astringency, and had good mouth usability.
显然,上述具体实施方式仅仅是为清楚地说明所作的举例,而并非对实施方式的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动。这里无需也无法对所有的实施方式予以穷举。而由此所引伸出的显而易见的变化或变动仍处于本发明创造的保护范围之中。Obviously, the above-mentioned specific embodiments are only examples for clear description, rather than limiting the embodiments. For those of ordinary skill in the art, changes or modifications in other different forms can also be made on the basis of the above description. There is no need and cannot be exhaustive of all implementations here. And the obvious changes or changes derived from this are still within the protection scope of the present invention.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210878310.8A CN115006296B (en) | 2022-07-25 | 2022-07-25 | A breath-removing composition containing biological zinc and its application in oral care products |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210878310.8A CN115006296B (en) | 2022-07-25 | 2022-07-25 | A breath-removing composition containing biological zinc and its application in oral care products |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115006296A true CN115006296A (en) | 2022-09-06 |
| CN115006296B CN115006296B (en) | 2024-12-20 |
Family
ID=83080503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210878310.8A Active CN115006296B (en) | 2022-07-25 | 2022-07-25 | A breath-removing composition containing biological zinc and its application in oral care products |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115006296B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000071090A1 (en) * | 1999-05-26 | 2000-11-30 | Dentsply International Inc. | Oral compositions for controlling mouth and breath odors containing a zinc salt |
| JP2006069989A (en) * | 2004-09-03 | 2006-03-16 | Kanebo Ltd | Bad breath remover and oral composition |
| CN102218021A (en) * | 2010-04-15 | 2011-10-19 | 刘钦 | Toothpaste for removing halitosis and preventing canker sore |
| US20170015811A1 (en) * | 2014-01-31 | 2017-01-19 | Innophos Inc. | Hydrogen sulfide scavenger |
| CN106994103A (en) * | 2016-01-26 | 2017-08-01 | 白育纶 | Mouthwash composition |
| CN107007482A (en) * | 2017-03-13 | 2017-08-04 | 广州薇美姿实业有限公司 | A kind of oral care implement for removing implication and preparation method thereof |
| CN111759757A (en) * | 2019-04-02 | 2020-10-13 | 白育纶 | Yeast organic zinc dentifrice composition and preparation method thereof |
-
2022
- 2022-07-25 CN CN202210878310.8A patent/CN115006296B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000071090A1 (en) * | 1999-05-26 | 2000-11-30 | Dentsply International Inc. | Oral compositions for controlling mouth and breath odors containing a zinc salt |
| JP2006069989A (en) * | 2004-09-03 | 2006-03-16 | Kanebo Ltd | Bad breath remover and oral composition |
| CN102218021A (en) * | 2010-04-15 | 2011-10-19 | 刘钦 | Toothpaste for removing halitosis and preventing canker sore |
| US20170015811A1 (en) * | 2014-01-31 | 2017-01-19 | Innophos Inc. | Hydrogen sulfide scavenger |
| CN106994103A (en) * | 2016-01-26 | 2017-08-01 | 白育纶 | Mouthwash composition |
| CN107007482A (en) * | 2017-03-13 | 2017-08-04 | 广州薇美姿实业有限公司 | A kind of oral care implement for removing implication and preparation method thereof |
| CN111759757A (en) * | 2019-04-02 | 2020-10-13 | 白育纶 | Yeast organic zinc dentifrice composition and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115006296B (en) | 2024-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| De Geest et al. | Periodontal diseases as a source of halitosis: a review of the evidence and treatment approaches for dentists and dental hygienists | |
| Quirynen et al. | Review of the treatment strategies for oral malodour | |
| Parashar | Mouthwashes and their use in different oral conditions | |
| JP2008069138A (en) | Oral composition | |
| CN108403544A (en) | A kind of Pediatric Oral Emergency care composition and preparation method thereof | |
| Hu et al. | A clinical investigation of the efficacy of a dual zinc plus arginine dentifrice for controlling oral malodor | |
| CN101829027B (en) | Multifunctional mouthwash | |
| Ennibi et al. | Chlorhexidine alcohol base mouthrinse versus Chlorhexidine formaldehyde base mouthrinse efficacy on plaque control: double blind, randomized clinical trials | |
| US20070098650A1 (en) | Dental formulation | |
| JP4730991B2 (en) | Oral composition | |
| CN107028784A (en) | A kind of oral care implement of fresh breath and preparation method thereof | |
| JP3706614B2 (en) | Oral composition for suppressing bad breath | |
| EP0486561B2 (en) | Buccal composition containing s(+) ketoprofen | |
| JP2016504279A (en) | Oral care composition containing theaflavin extract | |
| KR101071433B1 (en) | Composition for inhibiting halitosis | |
| US20040253193A1 (en) | Oral rinse for treatment for prevention of bacterial and fungal infection | |
| CN115006296B (en) | A breath-removing composition containing biological zinc and its application in oral care products | |
| KR101221074B1 (en) | Natural anti-bacterial toothpaste composition containing improvement in tooth pain, antibacterial mouth and nerve stability | |
| RU2188626C1 (en) | Pharmaceutical composition for preventing dental and periodontic diseases | |
| CN107007482A (en) | A kind of oral care implement for removing implication and preparation method thereof | |
| Wilhelm et al. | Short-term effect of a new mouthrinse formulation on oral malodour after single use in vivo: a comparative, randomized, single-blind, parallel-group clinical study | |
| CN115463043A (en) | Oral care composition and mouthwash | |
| KR20230037956A (en) | Functional toothpaste composition containing petroleum sulfur and extractive from a moxa cautery effective for the prevention and treatment of oral disease as active ingredients | |
| JPS63253019A (en) | Composition for oral cavity | |
| Young et al. | Effect of a single brushing with two Zn-containing toothpastes on VSC in morning breath: A 12 h, randomized, double-blind, cross-over clinical study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |